Head-to-head comparisons of medication uses, side effects, warnings, and more.
Dupixent (dupilumab)
Adbry (tralokinumab)
Dupixent (dupilumab)
Adbry (tralokinumab)
Summary of Dupixent vs. Adbry
Summary for Interleukin antagonist
Prescription only
Dupixent (dupilumab) is an injection that helps treat certain inflammatory conditions. This includes eczema, asthma, and chronic obstructive pulmonary disease (COPD), among others. It's a biologic medication known as an interleukin antagonist that lowers inflammation. Dupixent (dupilumab) comes as prefilled pens and prefilled syringes. It's injected under the skin of the belly or thighs (or in the back of the upper arm with someone's help). The dosing schedule depends on the condition you have, your age, and your weight. It's injected either every week, every 2 weeks, or every 4 weeks. Side effects include injection site reactions and eye problems.
Summary for Interleukin-13 (IL-13) antagonist
Prescription only
Adbry (tralokinumab or tralokinumab-ldrm) is biologic medication known as an interleukin antagonist. It treats moderate-to-severe eczema (also known as atopic dermatitis) in people ages 12 years and older. It's not a first-choice medication, but is only used when topical medications haven't worked well or aren't recommended. Adbry (tralokinumab) is injected under the skin every 2 to 4 weeks, under the guidance of a healthcare professional (HCP). If appropriate, your care team will teach you how to do self-injections at home. Some of the more common side effects of Adbry (tralokinumab) include upper respiratory tract infections.
Indications of Dupixent vs. Adbry
Indications for
•Moderate-to-severe eczema - for people 6 months and older
•Moderate-to-severe asthma - add-on maintenance for people 6 years and older